Kefir prevented excess fat accumulation in diet-induced obese mice

Bioscience, Biotechnology and Biochemistry

Volumn 81, Issue 5, 2017, Pages 958-965

  Choi, Jae Woo ^a   Kang, Hye Won ^b   Lim, Won Chul ^a   Kim, Mi Kyoung ^c   Lee, In Young ^c   Cho, Hong Yon ^a  

^a Korea University   (South Korea)

^b NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^c Naturene Co Ltd   (South Korea)

Author keywords

Kefir; Liver; Obesity; White adipose tissue

Indexed keywords

AMINO ACIDS; BIOSYNTHESIS; BODY FLUIDS; CHOLESTEROL; FATTY ACIDS; GENE EXPRESSION; GENES; GLYCEROL; LIVER; NUTRITION; TISSUE;

BODY FAT ACCUMULATION; FATTY ACID OXIDATION; HEPATIC TRIACYLGLYCEROL; KEFIR; LOW DENSITY LIPOPROTEINS; OBESITY; TOTAL CHOLESTEROLS; WHITE ADIPOSE TISSUES;

MAMMALS;

KEFIR; LIPID;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CELL SIZE; CHEMICALLY INDUCED; DRUG EFFECTS; EPIDIDYMIS; LIPID DIET; LIPOGENESIS; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; PATHOLOGY;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CELL SIZE; DIET, HIGH-FAT; EPIDIDYMIS; KEFIR; LIPIDS; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY;

EID: 85018612383     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2016.1258984     Document Type: Article

References (27)

1. Billington CJ, Epstein LH, Goodwin NJ, et al. Overweight, obesity, and health risk. Arch Intern Med. 2000;160:898-904.
2. Van Gaal LF, Mertens IL, De Block C. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.
3. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277-287.
4. Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36:461-470.
5. Laddu D, Dow C, Hingle M, et al. A review of evidence-based strategies to treat obesity in adults. Nutr Clin Pract. 2011;26:512-525.
6. de Oliveira Leite AM, Miguel MA, Peixoto RS, et al. Microbiological, technological and therapeutic properties of kefir: a natural probiotic beverage. Braz J Microbiol. 2013;44:341-349.
7. Bourrie BC, Willing BP, Cotter PD. The microbiota and health promoting characteristics of the fermented beverage kefir. Front Microbiol. 2016;7:1-17.
8. Chifiriuc MC, Cioaca AB, Lazar V. In vitro assay of the antimicrobial activity of kephir against bacterial and fungal strains. Anaerobe. 2011;17:433-435.
9. Medrano M, Racedo SM, Rolny IS, et al. Oral administration of kefiran induces changes in the balance of immune cells in a murine model. J Agric Food Chem. 2011;59:5299-5304.
10. Liu JR, Wang SY, Lin YY, et al. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutr Cancer. 2002;44:183-187.
11. Liu JR, Wang SY, Chen MJ, et al. Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters. Br J Nutr. 2006;95:939-946.
12. Huang Y, Wang X, Wang J, et al. Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity. J Dairy Sci. 2013;96:2746-2753.
13. Wang Y, Xu N, Xi A, et al. Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl Microbiol Biotechnol. 2009;84:341-347.
14. Yoshida Y, Yokoi W, Ohishi K, et al. Effects of the Cell Wall of Kluyveromyces marxianus YIT 8292 on the plasma cholesterol and fecal sterol excretion in rats fed on a high-cholesterol diet. Biosci Biotechnol Biochem. 2005;69:714-723.
15. Maeda H, Zhu X, Omura K, et al. Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation. Biofactors. 2004;22:197-200.
16. Chen HL, Tung YT, Tsai CL, et al. Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptindeficient ob/ob knockout mice. Int J Obes. 2014;38:1172-1179.
17. Ho J, Choi J, Lim W, et al. Kefir inhibits 3T3-L1 adipocyte differentiation through down-regulation of adipogenic transcription factor expression. J Sci Food Agric. 2013;93:485-490.
18. Ho J, Son M, Lim W, et al. Anti-obesity effects of germinated brown rice extract through down-regulation of lipogenic genes in high fat diet-induced obese mice. Biosci Biotechnol Biochem. 2012;76:1068-1074.
19. Lim W, Ho J, Lee H, et al. Germinated waxy black rice suppresses weight gain in high-fat diet-induced obese mice. J Med Food. 2016;19:410-417.
20. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78:783-809.
21. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184-6223.
22. Rosen ED, Walkey CJ, Puigserver P, et al. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293-1307.
23. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991;5:1538-1552.
24. Zhang YJ, Li S, Gan RY, et al. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015;16:7493-7519.
25. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85: 37-45.
26. Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr. 2014;99:1235S-1242S.
27. St-Onge MP, Farnworth ER, Savard T, et al. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810]. BMC Complement Altern Med. 2002;2:1-7.